Learn about Acute Lymphoblastic Leukemia ALL including its symptoms treatment options and survival rates Expert share ...

MSK experts believe that giving the targeted drug asciminib to patients with chronic myeloid leukemia at the beginning of ...

Practice-changing studies in frontline and relapsed/refractory chronic lymphocytic leukemia (CLL), presented ... favorable 5-year progression-free survival in the frontline setting.

A new study found that, overall, children with obesity at the time of their cancer diagnosis had worse survival rates ...

After adjusting for factors including age, sex, ethnicity, neighborhood income quintile, treatment era, and cancer categories ...

Obesity at cancer diagnosis appeared linked to significantly poorer survival among children and adolescents, according to ...

Two posters presented at the 2024 American Society of Hematology meeting reported real-world outcomes data for patients ...

Akriti Jain, MD, discusses her presentation from the 2024 American Society of Hematology Meeting and Exposition.

Amandeep Salhotra, MD, discussed the background and findings from a pilot trial evaluating enasidenib as post-hematopoietic ...